CD36-SREBP1轴介导肥胖加重特应性皮炎中的TSLP产生
该研究在小鼠中探讨肥胖加重特应性皮炎(AD)的机制,发现高脂饮食诱导的肥胖加重AD样皮炎,伴CD36-SREBP1相关脂肪酸蓄积和TSLP表达升高。化学抑制CD36或SREBP1可减轻肥胖MC903处理小鼠的AD样炎症、减少脂肪酸蓄积并下调TSLP。棕榈酸通过激活CD36-SREBP1通路诱导角质形成细胞TSLP过表达,SREBP1与TSLP启动子结合增加。
要点
- 高脂饮食诱导的肥胖小鼠AD样皮炎加重,皮损中CD36-SREBP1相关脂肪酸蓄积和TSLP表达升高
- 化学抑制CD36或SREBP1可减轻肥胖MC903处理小鼠的AD样炎症并下调TSLP
- 棕榈酸经CD36-SREBP1通路诱导角质形成细胞TSLP过表达,SREBP1与TSLP启动子结合增加
核心结论
- 肥胖触发角质形成细胞中CD36-SREBP1-TSLP轴激活,导致表皮脂质紊乱并加重AD样炎症。
- 作者认为靶向CD36或SREBP1可能有助于开发未来联合疗法或改良治疗策略,以管理同时患有肥胖和AD的患者。
研究设计与样本
- 研究采用高脂饮食诱导肥胖的小鼠模型,并结合卡泊三醇(MC903)处理的AD样小鼠模型进行在体实验。
- 体外实验使用角质形成细胞,以棕榈酸处理并通过染色质免疫沉淀实验检测SREBP1与TSLP启动子的结合。
- 原文摘要未报告样本量。
主要发现
- 高脂饮食诱导的肥胖小鼠AD样皮炎加重,皮损中炎症分子升高、CD36-SREBP1相关脂肪酸蓄积增加。
- 在肥胖MC903处理小鼠中,化学抑制CD36或SREBP1可有效减轻AD样炎症、减少脂肪酸蓄积并下调TSLP表达。
- 棕榈酸处理通过激活CD36-SREBP1信号通路诱导角质形成细胞TSLP过表达。
- 染色质免疫沉淀实验显示SREBP1与TSLP启动子区域的结合增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obesity is associated with an increased risk of atopic dermatitis (AD) and may accelerate its development. Keratinocyte dysfunction has been observed in obesity-related skin diseases, including psoriasis and acanthosis nigricans, but is not fully understood in AD. In this study, we found that high-fat diet-induced obesity exacerbated AD-like dermatitis in mice, with elevated inflammatory molecules and increased CD36-SREBP1-related fatty acid accumulation in the lesional skin. Blocking CD36 or SREBP1 with chemical inhibitors effectively alleviated AD-like inflammation, decreased fatty acid accumulation, and downregulated TSLP expression in obese calcipotriol (MC903)-treated mice. Moreover, palmitic acid treatment induced TSLP overexpression in keratinocytes through the activation of the CD36-SREBP1 signaling pathway. The chromatin immunoprecipitation assay further revealed increased binding of SREBP1 to the TSLP promoter region. Our findings provide compelling evidence that obesity triggers the activation of the CD36-SREBP1-TSLP axis in keratinocytes, leading to epidermal lipid disorders and the aggravation of AD-like inflammation. By targeting CD36 or SREBP1, future combination therapies or modified treatment strategies could be developed to help manage patients with both obesity and AD.
引用
- Yu J, Song P, Bai Y, et al. CD36-SREBP1 Axis Mediates TSLP Production in Obesity-Exacerbated Atopic Dermatitis. J Invest Dermatol. 2023. PMID: 37209865. doi:10.1016/j.jid.2023.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。